Delivery Order SPE2DB22D3501-SPE2DB24FWR29

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has a ceiling value of $3,498.20 and an ultimate completion date of September 4, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,527.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of OMNIPAQUE 300 MG/ML VIAL 10ML, a medical product, with a completion date of February 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,057.92 fixed-price contract is for the supply of Omnipaque 350 mg/ml PlusPak 500 ml medical products to support federal healthcare programs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,669.73 firm-fixed-price contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has an ultimate completion date of January 2, 2024 and was awarded on December 29, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Omnipaque 300 mg/ml infusion bottles (150 ml) to the Defense Logistics Agency (DLA). The $1,800.47 Firm Fixed Price contract is a Delivery Order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,399.28, is for the supply of Omnipaque 350 mg/ml medical imaging contrast media. The contract has a firm fixed price and an ultimate completion date of May 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.50 firm fixed-price contract is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a medical product used in healthcare settings. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products such as Omnipaque 350 mg/ml PlusePak 500 ml. The delivery order has a ceiling value of $3,293.85 and a completion date of June 7, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,141.62, is a delivery order for the medical product "OMNIPAQUE 300 MG/ML PLUSPAK 500ML". The contract has an ultimate completion date of March 11, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML to the Defense Logistics Agency (DLA). The award, valued at $2,645.60, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWR29
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Omnipaque 300 mg/ml medical products. The $2,179.18 firm-fixed-price contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 11/15/24, 9:25 AM